Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,642 | -10,710 | -5,380 | -1,140 | 3,370 |
| Depreciation Amortization | 9 | 20 | 60 | 60 | 50 |
| Accounts payable and accrued liabilities | 318 | -770 | N/A | N/A | N/A |
| Other Working Capital | 1,024 | -3,350 | -1,860 | 0 | -1,900 |
| Other Operating Activity | -81 | 2,590 | 890 | -1,400 | 150 |
| Operating Cash Flow | $-3,372 | $-12,220 | $-6,290 | $-2,480 | $1,670 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,000 | -7,000 | N/A | N/A | N/A |
| PPE Investments | -2 | -70 | -30 | -30 | -20 |
| Sale Of Investment | N/A | 243 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -75 | -1,035 | N/A | N/A | N/A |
| Other Investing Activity | -75 | -11,033 | -17,780 | -16,750 | 0 |
| Investing Cash Flow | $-7,077 | $-17,860 | $-17,810 | $-16,780 | $-20 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,198 | 24,369 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -9 | 24,360 | 24,350 | 23,820 |
| Financing Cash Flow | $13,198 | $24,360 | $24,360 | $24,350 | $23,820 |
| Exchange Rate Effect | -167 | -230 | -100 | 210 | 80 |
| Beginning Cash Position | 5,892 | 11,850 | 11,850 | 11,850 | 11,850 |
| End Cash Position | 8,474 | 5,890 | 12,000 | 17,140 | 37,410 |
| Net Cash Flow | $2,582 | $-5,950 | $150 | $5,290 | $25,560 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,372 | -12,220 | -6,290 | -2,480 | 1,670 |
| Capital Expenditure | -2 | -70 | N/A | N/A | N/A |
| Free Cash Flow | -3,374 | -12,290 | -6,290 | -2,480 | 1,670 |